In the BioHarmony Drug Report Database

"Preview" Icon

Ceftibuten

Cedax (ceftibuten) is a small molecule pharmaceutical. Ceftibuten was first approved as Cedax on 1995-12-20. It is used to treat bacterial infections, bronchitis, escherichia coli infections, haemophilus infections, and klebsiella infections amongst others in the USA.

 

Trade Name

 

Cedax
 

Common Name

 

ceftibuten
 

ChEMBL ID

 

CHEMBL1605
 

Indication

 

bacterial infections, bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections, otitis media, streptococcal infections, tonsillitis
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Ceftibuten structure rendering